Remus Pharmaceuticals Ltd. (REMUS-SM): Remus Pharmaceuticals Share Price rises 10.07% to Rs 953.55
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Remus Pharmaceuticals Share Price rose 10.07% today to Rs 953.55, with market capitalisation at Rs 1,042.65 crore. The stock opened at Rs 883, touched an intraday high of Rs 963 and low of Rs 883, and the supplied data confirms the price event without establishing a company-specific catalyst. In today’s Stock Market Today context, the move places Remus Pharmaceuticals Stock News among the notable Stocks in News, while the turnover of Rs 1.13 crore gives a factual trading-value snapshot. Univest is tracking the move through the Remus Pharmaceuticals Share Price Today update, alongside valuation, sector and peer context.
For readers searching Remus Pharmaceuticals Share Price, Remus Pharmaceuticals Share Price Today or Remus Pharmaceuticals Stock News, the important takeaway is straightforward: the share price gain is real, the day’s range is wide relative to the previous close, and the move needs to be read alongside the company’s fundamentals and Trading sector benchmarks. Univest is presenting the facts first so that investors can separate the price rise from any unverified explanation.
Remus Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 953.55 |
| Previous Close | Rs 866.35 |
| Today's Move | Rs 87.2 (+10.07%) |
| Open | Rs 883 |
| High | Rs 963 |
| Low | Rs 883 |
| Turnover | Rs 1.13 crore |
| Market Capitalisation | Rs 1,042.65 crore |
| Market Cap Category | Small Cap |
Remus Pharmaceuticals Ltd. (REMUS-SM) rose to Rs 953.55 from the previous close of Rs 866.35, a move of Rs 87.2 or 10.07%. The stock opened at Rs 883, reached a high of Rs 963, recorded a low of Rs 883.
Remus Pharmaceuticals Share Price Today moved from the previous close of Rs 866.35 to Rs 953.55, a gain of Rs 87.20 or 10.07%. The stock opened at Rs 883, traded between Rs 883 and Rs 963 during the session, and ended close to the upper end of that band. The turnover stood at Rs 1.13 crore. This is the day’s factual price action, and the supplied data confirms the rise without identifying a specific trigger. For readers following Remus Pharmaceuticals Share Price Live or Remus Pharmaceuticals Share Price Update, the session shows a clear one-day gain, not a separate 52 Week High or record-high claim.
In market-news terms, Remus Pharmaceuticals Stock Gaining Today stands out because the move was large enough to draw attention in Indian Stock Market screens, yet the verified data stays limited to the price path, turnover and market capitalisation. Univest is keeping the analysis grounded in observed facts rather than assuming a cause.
Remus Pharmaceuticals Ltd. (REMUS-SM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 1,042.65 crore |
| P/E Ratio | 27.6x |
| P/B Ratio | 2.91x |
| ROE | 18.58% |
| ROCE | 21.89% |
| EPS | Rs 31.39 |
| Book Value Per Share | Rs 297.86 |
| Dividend Yield | 0.12% |
Remus Pharmaceuticals Ltd. (REMUS-SM) fundamental metrics show P/E 27.6x, P/B 2.91x, ROE 18.58%, ROCE 21.89%. These figures provide context only and are not a buy or sell signal.
Remus Pharmaceuticals Ltd. has a market capitalisation of Rs 1042.65 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.6x, P/B at 2.91x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.58% and ROCE of 21.89%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 31.39, book value per share of Rs 297.86, dividend yield of 0.12%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 23.28x, median ROE of 4.1%, median ROCE of 6.09%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Trading |
| Industry | Trading |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.6x |
| Benchmark Median P/E | 23.28x |
| Benchmark Average P/E | 112.43x |
| Benchmark P/E Range | 0.12x to 8,715.25x |
| Company P/B Ratio | 2.91x |
| Benchmark Median P/B | 1.37x |
| Company ROE | 18.58% |
| Benchmark Median ROE | 4.1% |
| Company ROCE | 21.89% |
| Benchmark Median ROCE | 6.09% |
| Company Market Capitalisation | Rs 1,042.65 crore |
| Benchmark Median Market Cap | Rs 52.76 crore |
Remus Pharmaceuticals Ltd. (REMUS-SM) is classified under sector: Trading and industry: Trading.
Remus Pharmaceuticals Ltd. (REMUS-SM) has a P/E ratio of 27.6x, which is above the benchmark median of 23.28x, a difference of +18.56%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Remus Pharmaceuticals Ltd. (REMUS-SM) has a ROE of 18.58%, which is above the benchmark median of 4.1%, a difference of +353.17%. Remus Pharmaceuticals Ltd. (REMUS-SM) has a ROCE of 21.89%, which is above the benchmark median of 6.09%, a difference of +259.44%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Adani Enterprises Ltd. | ADANIENT | 3,96,911.47 | 53.17 | 4.2 | 15.07 | 13.3 |
| Aegis Logistics Ltd. | AEGISLOG | 46,458.36 | 38.75 | 7.35 | 20.71 | 19.76 |
| ADITYA INFOTECH LIMITED | CPPLUS | 43,295 | 87.91 | 20.81 | 25.68 | 29.48 |
| Premier Energies Ltd. | PREMIERENE | 42,989.21 | 24.51 | 8.58 | 42.6 | 33.72 |
| Redington Ltd. | REDINGTON | 29,566.71 | 17.84 | 2.86 | 13.6 | 18.96 |
Remus Pharmaceuticals Ltd. (REMUS-SM) has a P/E ratio of 27.6x compared with the displayed peer median of 38.75x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.58% compares with a peer median of 20.71% across the companies shown in the table. ROCE stood at 21.89% versus the displayed peer median of 19.76%, providing a capital-efficiency comparison. Remus Pharmaceuticals Ltd. (REMUS-SM) has a market capitalisation of Rs 1,042.65 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Remus Pharmaceuticals
- Remus Pharmaceuticals Share Price rose 10.07% today to Rs 953.55 from the previous close of Rs 866.35.
- The session ranged from Rs 883 to Rs 963, which gives a clear intraday price band for Remus Pharmaceuticals Share Price Today.
- Market capitalisation stands at Rs 1,042.65 crore, placing the company above the sector median size of Rs 52.76 crore.
- ROE of 18.58% and ROCE of 21.89% are above the Trading sector medians in the supplied benchmark.
- Remus Pharmaceuticals Share Price carries a P/E of 27.6 and a P/B of 2.91, both useful for sector and peer comparison.
About Remus Pharmaceuticals
Remus Pharmaceuticals Ltd. is covered here as a Trading sector and Trading industry company. The supplied data does not add product or segment detail, so the factual company view must stay anchored to the financial and market information provided. From the available numbers, the business is being tracked through its market capitalisation of Rs 1,042.65 crore, earnings profile, valuation ratios and price movement on the day. That is enough to frame a basic company overview for readers searching Remus Pharmaceuticals Share Price, Remus Pharmaceuticals Company News and Remus Pharmaceuticals Stock News.
For Univest readers, the most relevant company context is that this is a listed Trading name with above-median return ratios in the sector benchmark and a current share price that moved sharply higher today. The article focuses on the verified financial and market signals that help explain why the stock is appearing in stock updates and market movers coverage.
Track Remus Pharmaceuticals Share Price on Univest
Use Remus Pharmaceuticals Ltd. (REMUS-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
You can track Remus Pharmaceuticals Share Price on Univest for live price updates, financial ratios, shareholding pattern, 52-week levels and market insights. The platform also brings together Remus Pharmaceuticals Share Price Today, Remus Pharmaceuticals Fundamental Analysis and Remus Pharmaceuticals Stock Analysis in one place. Univest keeps the presentation factual so readers can compare the move with sector and peer benchmarks.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Remus Pharmaceuticals Share Price rise today?
Ans. The supplied data confirms that Remus Pharmaceuticals Share Price rose 10.07% today, but it does not establish a company-specific catalyst. The move is supported by observed price action, turnover and market capitalisation, not by an identified announcement.
What is Remus Pharmaceuticals Share Price today?
Ans. Remus Pharmaceuticals Share Price today is Rs 953.55. It moved up from the previous close of Rs 866.35 and finished after trading between Rs 883 and Rs 963 during the session.
How much did Remus Pharmaceuticals stock gain today?
Ans. Remus Pharmaceuticals stock gained Rs 87.20 today, which translates to 10.07%. That makes it a notable same-day share price rise, with the day’s turnover at Rs 1.13 crore. The previous close was Rs 866.35.
What is the market capitalisation of Remus Pharmaceuticals?
Ans. Remus Pharmaceuticals has a market capitalisation of Rs 1,042.65 crore. Market cap reflects company size, not quality, and it should be read alongside valuation and return ratios for context. The company operates in the Trading sector.
How does Remus Pharmaceuticals compare with Trading sector benchmarks?
Ans. Remus Pharmaceuticals has a P/E of 27.6 and ROE of 18.58%, both above the sector medians of 23.28 and 4.1% respectively. Its ROCE of 21.89% also stands above the benchmark median.
What does Remus Pharmaceuticals fundamental analysis show?
Ans. Remus Pharmaceuticals fundamental analysis shows EPS of Rs 31.39, book value of Rs 297.86 and dividend yield of 0.12%. These figures help explain earnings, accounting value and payout context around the share price.
How does Remus Pharmaceuticals compare with peers on valuation?
Ans. Remus Pharmaceuticals Share Price is backed by a P/E of 27.6, below Adani Enterprises, Aegis Logistics and ADITYA INFOTECH LIMITED, but above Redington. That places it in the middle of the supplied peer range.
Where can I track Remus Pharmaceuticals Share Price on Univest?
Ans. Investors can track Remus Pharmaceuticals Share Price on Univest for live price updates, financial ratios, shareholding pattern and market insights. The page also consolidates sector context and peer comparison for quick review.
